These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 11024027
21. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Nijenhuis WA, Oosterom J, Adan RA. Mol Endocrinol; 2001 Jan; 15(1):164-71. PubMed ID: 11145747 [Abstract] [Full Text] [Related]
22. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH. Mountjoy KG, Willard DH, Wilkison WO. Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968 [Abstract] [Full Text] [Related]
23. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist. Xiang Z, Proneth B, Dirain ML, Litherland SA, Haskell-Luevano C. Biochemistry; 2010 Jun 08; 49(22):4583-600. PubMed ID: 20462274 [Abstract] [Full Text] [Related]
24. Contribution of melanocortin receptor exoloops to Agouti-related protein binding. Yang YK, Dickinson CJ, Zeng Q, Li JY, Thompson DA, Gantz I. J Biol Chem; 1999 May 14; 274(20):14100-6. PubMed ID: 10318826 [Abstract] [Full Text] [Related]
25. Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor. Navarro M, Cubero I, Chen AS, Chen HY, Knapp DJ, Breese GR, Marsh DJ, Thiele TE. Alcohol Clin Exp Res; 2005 Jun 14; 29(6):949-57. PubMed ID: 15976520 [Abstract] [Full Text] [Related]
26. The interaction of MC3R and MC4R with MRAP2, ACTH, α-MSH and AgRP in chickens. Zhang J, Li X, Zhou Y, Cui L, Li J, Wu C, Wan Y, Li J, Wang Y. J Endocrinol; 2017 Aug 14; 234(2):155-174. PubMed ID: 28512117 [Abstract] [Full Text] [Related]
27. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position. Holder JR, Xiang Z, Bauzo RM, Haskell-Luevano C. J Med Chem; 2002 Dec 19; 45(26):5736-44. PubMed ID: 12477357 [Abstract] [Full Text] [Related]
28. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein. McNulty JC, Thompson DA, Bolin KA, Wilken J, Barsh GS, Millhauser GL. Biochemistry; 2001 Dec 25; 40(51):15520-7. PubMed ID: 11747427 [Abstract] [Full Text] [Related]
30. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. Haskell-Luevano C, Hendrata S, North C, Sawyer TK, Hadley ME, Hruby VJ, Dickinson C, Gantz I. J Med Chem; 1997 Jul 04; 40(14):2133-9. PubMed ID: 9216831 [Abstract] [Full Text] [Related]
31. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Yang YK, Fong TM, Dickinson CJ, Mao C, Li JY, Tota MR, Mosley R, Van Der Ploeg LH, Gantz I. Biochemistry; 2000 Dec 05; 39(48):14900-11. PubMed ID: 11101306 [Abstract] [Full Text] [Related]
32. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors. Tota MR, Smith TS, Mao C, MacNeil T, Mosley RT, Van der Ploeg LH, Fong TM. Biochemistry; 1999 Jan 19; 38(3):897-904. PubMed ID: 9893984 [Abstract] [Full Text] [Related]
33. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position. Holder JR, Bauzo RM, Xiang Z, Haskell-Luevano C. J Med Chem; 2002 Jul 04; 45(14):3073-81. PubMed ID: 12086493 [Abstract] [Full Text] [Related]
34. Molecular pharmacology of Agouti protein in vitro and in vivo. Barsh GS, Ollmann MM, Wilson BD, Miller KA, Gunn TM. Ann N Y Acad Sci; 1999 Oct 20; 885():143-52. PubMed ID: 10816647 [Abstract] [Full Text] [Related]
35. Melanocortin peptides stimulate prolactin gene expression and prolactin accumulation in rat pituitary aggregate cell cultures. Langouche L, Hersmus N, Papageorgiou A, Vankelecom H, Denef C. J Neuroendocrinol; 2004 Aug 20; 16(8):695-703. PubMed ID: 15271062 [Abstract] [Full Text] [Related]
36. Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles. Ericson MD, Koerperich ZM, Freeman KT, Fleming KA, Haskell-Luevano C. ACS Chem Neurosci; 2018 Dec 19; 9(12):3015-3023. PubMed ID: 29924583 [Abstract] [Full Text] [Related]
37. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors. Haskell-Luevano C, Holder JR, Monck EK, Bauzo RM. J Med Chem; 2001 Jun 21; 44(13):2247-52. PubMed ID: 11405661 [Abstract] [Full Text] [Related]
38. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position. Holder JR, Bauzo RM, Xiang Z, Haskell-Luevano C. J Med Chem; 2002 Jun 20; 45(13):2801-10. PubMed ID: 12061882 [Abstract] [Full Text] [Related]
39. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors. Kim MS, Small CJ, Russell SH, Morgan DG, Abbott CR, alAhmed SH, Hay DL, Ghatei MA, Smith DM, Bloom SR. J Neuroendocrinol; 2002 Apr 20; 14(4):276-82. PubMed ID: 11963824 [Abstract] [Full Text] [Related]